Sangare Moussa, Berthe Adama, Dolo Housseini, Diabaté Abdoul Fatao, Konipo Fatoumata Dite Nènè, Soumaoro Lamine, Doumbia Salif Seriba, Coulibaly Michel Emmanuel, Diarra Lamine, Sanogo Yacouba, Atsou Kueshivi Midodji, Diallo Abdallah Amadou, Coulibaly Siaka Yamoussa, Keita Modibo, Doumbia Seydou, Coulibaly Yaya Ibrahim
International Center for Excellence in Research Mali (ICER-Mali), University of Sciences, Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
International Center for Excellence in Research Mali (ICER-Mali), University of Sciences, Techniques, and Technologies of Bamako (USTTB), Bamako, Mali.
Int J Infect Dis. 2021 Nov;112:196-201. doi: 10.1016/j.ijid.2021.08.063. Epub 2021 Sep 2.
In 2004, Mali implemented mass drug administration (MDA) aimed at controlling schistosomiasis and soil-transmitted helminths. Despite several rounds of MDA, the health district of Bankass reported low coverage (64.8%) for praziquantel and albendazole in 2017, meaning that this district was still facing challenges in accomplishing the targeted 75% coverage. This study aimed to explore the barriers and gaps that hindered MDA implementation in Bankass.
A cross-sectional study was performed. Questionnaires were administrated to all school-aged children in randomly selected villages. Technical directors of community health centers and community drug distributors in the selected villages were included in the interviews.
A total of 2128 children and 52 health workers were interviewed. Coverage rates were 93.51% (1990/2128) for praziquantel and 95.25% (2027/2128) for albendazole. Among the untreated children, 31.63% (31/98) reported being unaware of the campaign and 26.53% (26/98) were unable to reach the distribution points. Most of the health workers suggested increasing incentives.
The data showed satisfactory coverage >90%, in contrast with lower rates initially reported by the district health information system. These results raise concerns about the reliability of programmatic data and highlight the importance of population-based surveys for the evaluation of control interventions.
2004年，马里实施了旨在控制血吸虫病和土壤传播蠕虫的群体药物管理（MDA）。尽管进行了几轮MDA，但班卡斯卫生区在2017年报告吡喹酮和阿苯达唑的覆盖率较低（64.8%），这意味着该地区在实现目标覆盖率75%方面仍面临挑战。本研究旨在探讨阻碍班卡斯实施MDA的障碍和差距。
进行了一项横断面研究。对随机选择村庄的所有学龄儿童进行问卷调查。选定村庄的社区卫生中心技术主任和社区药品分发人员也纳入访谈。
共访谈了2128名儿童和52名卫生工作者。吡喹酮的覆盖率为93.51%（1990/2128），阿苯达唑的覆盖率为95.25%（2027/2128）。在未接受治疗的儿童中，31.63%（31/98）表示不知道该活动，26.53%（26/98）无法到达分发点。大多数卫生工作者建议增加激励措施。
数据显示覆盖率>90%，令人满意，这与地区卫生信息系统最初报告的较低覆盖率形成对比。这些结果引发了对项目数据可靠性的担忧，并突出了基于人群的调查对评估控制干预措施的重要性。
